Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion

JCO Precis Oncol. 2023 Jul:7:e2300065. doi: 10.1200/PO.23.00065.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Child
  • Gene Fusion
  • Humans
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / genetics
  • Proto-Oncogene Proteins B-raf* / genetics
  • Sarcoma* / drug therapy
  • Sarcoma* / genetics
  • Sorting Nexins / genetics

Substances

  • Biomarkers, Tumor
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • SNX8 protein, human
  • Sorting Nexins
  • tovorafenib